Skip to content
Back to event

KalshiKalshi· Science and Technology

When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?

Chance

88%

Buy Yes

92¢

pays $1 if it happens

Buy No

16¢

pays $1 if it doesn’t

Prices from Kalshi, updated 12 minutes ago. Ends Jul 1, 3:59 AM UTC.

Price over the last 2 weeks
Cost of a Yes share

Latest trades

  • 6 hours agoBought no at 14¢$9
  • 6 hours agoBought no at 13¢$1
How this market is decidedShow

If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes.